Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment

PURPOSE: Breast cancer (BC) patients with T1N0 tumors have relatively favorable clinical outcomes. However, it remains unclear whether molecular subtypes can aide in prognostic prediction for such small, nodal-negative BC cases and guide decision-making about escalating or de-escalating treatments....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Siji, Li, Yafen, Chen, Weiguo, Fei, Xiaochun, Shen, Kunwei, Chen, Xiaosong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933524/
https://www.ncbi.nlm.nih.gov/pubmed/33680973
http://dx.doi.org/10.3389/fonc.2021.636266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933524/
https://www.ncbi.nlm.nih.gov/pubmed/33680973
http://dx.doi.org/10.3389/fonc.2021.636266

Ejemplares similares